Generic formulation

EFAVIRENZ + EMTRICITABINE + TENOFOVIR DISOPROXIL FUMARATE

1 Uganda record

Browse branded medicines

Active ingredients

efavirenz + emtricitabine + tenofovir disoproxil

Active ingredients: 3
Individual monographs: 6 available
Uganda registered products: 1

Jurisdiction: UGSource: Uganda National Drug Register, July 2024

Individual drug information

Clinical information is kept separate for each active ingredient in this formulation.

efavirenz

3 reference sources available

Mosby’s 2024 MSF Essential Drugs (January 2026) BNF 80 (2020–2021)

emtricitabine

2 reference sources available

Mosby’s 2024 BNF 80 (2020–2021)

tenofovir disoproxil

1 reference source available

BNF 80 (2020–2021)

Combination products do not use one blanket clinical monograph here. Open an ingredient above to read the information extracted for that individual drug.

Uganda registered brands

Products linked to this generic formulation in the National Drug Register.

EFAVIRENZ+EMTR ICITABINE+TENOF OVIR DISOPROXILEFAVIRENZ + EMTRICITABINE + TENOFOVIR DISOPROXIL FUMARATE

600MG +200MG + 300MG · ORAL SOLID ORDINARY FILM- COATED TABLETS

AUROBINDO PHARMA LTDUG · NDA/MAL/HDP/5281

View details

Professional reference only. A Uganda registration record does not confirm current availability or that a product is appropriate for a particular patient. Verify current guidelines, diagnosis, dose, route, contraindications, interactions and regulatory status before prescribing.